In a first approach to assess the role of LTα3 in the effector phase of arthritis, C57BL/6 mice were treated with antibody specific for LTα3 or with ETA that neutralizes mouse TNF, as well as LTα3. This evidence concerns the gene TNF and arthritic joint disease.